Detalles de la búsqueda
1.
Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates.
J Virol
; 97(1): e0163822, 2023 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36511698
2.
Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring.
Ther Drug Monit
; 46(1): 80-88, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37735762
3.
Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.
Proc Natl Acad Sci U S A
; 118(17)2021 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33875584
4.
Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
J Infect Dis
; 225(2): 317-326, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33844021
5.
A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid.
Antimicrob Agents Chemother
; 65(10): e0103921, 2021 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34228546
6.
A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor.
J Virol
; 94(19)2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32611758
7.
Utility of the Rapid Antigen Detection Test E. histolytica Quik Chek for the Diagnosis of Entamoeba histolytica Infection in Nonendemic Situations.
J Clin Microbiol
; 58(11)2020 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32878955
8.
Erratum to: Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
J Infect Dis
; 225(2): 359, 2022 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34865054
9.
C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir.
J Virol
; 90(5): 2180-94, 2015 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581995
10.
Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report.
Hematol Rep
; 16(2): 185-192, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38651448
11.
Conversion of raltegravir carrying a 1,3,4-oxadiazole ring to a hydrolysis product upon pH changes decreases its antiviral activity.
PNAS Nexus
; 3(1): pgad446, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38170115
12.
CCR5 inhibitors: emergence, success, and challenges.
Expert Opin Emerg Drugs
; 17(2): 135-45, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22533737
13.
t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity.
Biomolecules
; 12(9)2022 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36139072
14.
Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan.
J Glob Antimicrob Resist
; 29: 247-252, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429667
15.
Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study.
Microbiol Spectr
; 9(1): e0035521, 2021 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34346742
16.
GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.
Antimicrob Agents Chemother
; 53(3): 997-1006, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18955518
17.
Potent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase 3 knockout mice.
Antimicrob Agents Chemother
; 53(9): 3887-93, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19546363
18.
Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s.
Sci Rep
; 9(1): 4828, 2019 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30886166
19.
2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants.
Int J Biochem Cell Biol
; 40(11): 2410-20, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18487070
20.
Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs.
Antimicrob Agents Chemother
; 52(6): 2111-9, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18378711